Flagship explainer
What drives CG Oncology, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$161M | FY2025 |
| |
| Income before tax | −$161M | FY2025 |
|
| Operating income | −$191M | FY2025 |
|
| $4M | FY2025 |
| |
| Ending assets | $792M | FY2025 |
|
| Beginning assets | $755M | FY2024 |
|
| $753M | FY2025 |
| |
| $733M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-079498